Medicines Discovery Catapult upgrade to MOLECUBES preclinical PET/CT system
28th July 2021
Medicines Discovery Catapult (MDC), headquartered at Alderley Park, recently decided to upgrade its preclinical imaging platform with the addition of a state-of-the-art modular benchtop preclinical PET/CT system from MOLECUBES.
Accelerating translational research in the UK
This will help to enable the UK SME community access advanced preclinical imaging technologies and as such have a significant impact on accelerating translational research and new drug discovery.
UK training and support for MOLECUBES
Southern Scientific works closely with MOLECUBES to ensure continuity in the UK in these challenging times. We pride ourselves on being a knowledgeable and experienced partner to carry out installations and provide training and support when our customers need it. We look forward to a successful long-term collaboration with MDC.